Pantoprazole Teva (Pantoprazole)

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.
• Helicobacter pylori eradication regimens (as part of combination therapy): enhances eradication rates when used with antibiotics.
• NSA‑induced ulcer prophylaxis: lowers the risk of ulcer development in patients requiring long‑term NSAID therapy.

• Pantoprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly reduces both basal and stimulated gastric acidity, allowing mucosal healing and symptom control in acid‑related disorders.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually transient.
• Nausea or abdominal discomfort: occasional.
• Flatulence: mild bloating.
• Constipation: occasional.
• Dry mouth: mild.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): requires immediate medical attention.
• Clostridioides difficile‑associated colitis: may present with persistent diarrhea.
• Low magnesium levels (hypomagnesemia): can cause muscle cramps or arrhythmias.
• Bone fractures (with long‑term use): increased risk of hip, wrist or spine fractures.
• Liver enzyme elevations: may indicate hepatic stress.
• Acute interstitial nephritis: rare kidney inflammation.

When using Pantoprazole, consider the following precautions:

• Assess renal function: dose adjustment may be needed in severe impairment.
• Review concomitant medications: potential for altered absorption of drugs requiring acidic pH.
• Monitor long‑term therapy: evaluate need for continued treatment after 12 months.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Elderly patients: start with the lowest effective dose and monitor for fractures.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid)

• Antifungal agents (ketoconazole, itraconazole): reduced absorption and efficacy.
• HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely)

• Antiplatelet drug clopidogrel: possible reduction in antiplatelet effect.
• Warfarin: may increase INR and bleeding risk.
• Methotrexate (high dose): reduced renal clearance leading to toxicity.
• Digoxin: increased serum levels.
• Iron supplements: decreased absorption; separate dosing by at least 2 hours.